OnKure Therapeutics, Inc. OKUR Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s total operating expenses?
- OnKure Therapeutics, Inc. (OKUR) reported total operating expenses of $15.62M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s total operating expenses changed year-over-year?
- OnKure Therapeutics, Inc.'s total operating expenses decreased by 8.1% year-over-year, from $17M to $15.62M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s total operating expenses?
- Over 3 years (2021 to 2025), OnKure Therapeutics, Inc.'s total operating expenses has grown at a 16.5% compound annual growth rate (CAGR), from $39.82M to $62.95M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.